Cherry et al.
2H), 2.21 (s, 3H), 2.33 (t, J ) 7.3 Hz, 2H), 5.87 (s, 1H), 5.92 (s,
1H); 13C NMR (50 MHz, CDCl3) δ 13.5, 19.7, 21.3, 37.8, 105.6,
109.6, 161.0, 161.9, 164.1; MS (EI) m/z (%) 152 (M•+, 36), 124
(24), 96 (100), 95 (43), 43 (83). Anal. Calcd for C9H12O2: C,
71.03; H, 7.95. Found: C, 71.09; H, 8.0.
An alternative pathway involving the vinylic palladium
addition to the central carbon atom of the stannylallene
could be excluded on the basis of the experiments
conducted with 1- or 3-substituted allenylstannanes
because other regioisomers should have been obtained
rather than 3a-k or 5a-g.22
On the other hand, an isomerization of allene to alkyne
prior to nucleophilic attack of the carboxylate function
is also excluded, because, in this case, a probable mixture
of five- and six-membered ring products will be formed.30-32
6-Methyl-4-phenyl-2H-pyran-2-one (3d).37 IR (neat) 2960,
2926, 2855, 1741, 1725, 1642, 1552; 1H NMR (200 MHz, CDCl3)
δ 2.35 (bs, 3H), 6.35 (bs, 1H), 6.38 (s, 1H), 7.31-7.62 (m, 5H);
13C NMR (50 MHz, CDCl3) δ 20.7, 104, 108.8, 127.3, 129.7,
131, 137, 157, 162.7, 163; MS (EI) m/z (%) 186 (M•+, 53), 158
(100), 129 (40), 115 (69), 51 (15), 43 (39). Anal. Calcd for
C12H10O2: C, 77.40; H, 5.41. Found: C, 77.36; H, 5.36.
6-Methyl-4-trimethylsilyl-2H-pyran-2-one (3e). IR (neat)
2960, 1764, 1730, 1624, 1523, 1253; 1H NMR (200 MHz, CDCl3)
δ 0.23 (s, 9H), 2.23 (bs, 3H), 5.97-6.0 (m, 1H), 6.28 (bs, 1H);
13C NMR (50 MHz, CDCl3) δ -0.8, 14, 105.7, 118, 160.3, 160.4,
161.6; MS (EI) m/z (%) 182 (M•+, 19), 154 (27), 139 (100), 73
(49), 43 (60). Anal. Calcd for C9H14O2Si: C, 59.30; H, 7.74.
Found: C, 59.35; H, 7.80.
Conclusion
In summary, we have developed a general and conve-
nient regioselective method for the preparation of 3-sub-
stituted isocoumarins and substituted R-pyrones via the
palladium-catalyzed coupling of 2-iodobenzoic acid de-
rivatives or vinylic acids and allenyltributyltins. The
heteroannulation reaction proceeded selectively and pro-
vided good isolated yields of a variety of 3-substituted
isocoumarins and substituted R-pyrones.
4-Methoxymethyl-6-methyl-2H-pyran-2-one (3f). IR
(neat) 2995, 2928, 2824, 1738, 1715, 1645, 1568, 1449, 1308,
1
1199; H NMR (200 MHz, CDCl3) δ 2.2 (s, 3H), 3.38 (s, 3H),
4.18 (bs, 2H), 5.92 (bs, 1H), 6.08 (bs, 1H); 13C NMR (50 MHz,
CDCl3) δ 20.5, 59.4, 72.5, 103, 109, 156.7, 162.7, 163.5; MS
(EI) m/z (%) 154 (M•+, 22), 122 (21), 95 (28), 45 (19), 43 (100).
Anal. Calcd for C8H10O3: C, 62.33; H, 6.54. Found: C, 62.28;
H, 6.48.
Experimental Section
6-Ethyl-4-methyl-2H-pyran-2-one (3g).38 IR (neat) 2981,
2977, 2968, 1713, 1644; 1H NMR (CDCl3, 200 MHz) δ 1.05 (t,
J ) 7.5 Hz, 3H), 1.97 (s, 3H), 2.33 (t, J ) 7.5 Hz, 2H), 5.73
(bs, 1H), 5.77 (bs, 1H); 13C NMR (CDCl3, 50 MHz) δ 11.3, 22.9,
27.1, 105.2, 110.7, 156.9, 163.6, 166.3; MS (EI) m/z (%) 138
(M•+, 53), 111 (51), 109 (100), 95 (63), 53 (92). Anal. Calcd for
C8H10O2: C, 69.54; H, 7.30. Found: C, 69.49; H, 7.27.
6-Ethyl-4-trimethylsilyl-2H-pyran-2-one (3h). IR (neat)
2960, 1745, 1727, 1622, 1523, 1255; 1H NMR (200 MHz, CDCl3)
δ 0.17 (s, 9H), 1.15 (t, J ) 7.5 Hz, 3H), 2.41 (q, J ) 7.5 Hz,
2H), 5.90 (s, 1H), 6.19 (s, 1H); 13C NMR (CDCl3, 50 MHz) δ
-2.1, 11.7, 27.3, 104.6, 118.6, 162.2, 163.1, 165.5; MS (EI) m/z
(%) 196 (M•+, 22), 168 (30), 153 (100), 75 (15), 57 (17). Anal.
Calcd for C10H16O2Si: C, 61.18; H, 8.21. Found: C, 61.13; H,
8.13.
General Procedure for the Preparation of r-Pyrones
3a-k. Palladium acetate (112 mg, 0.5 mmol), triphenylphos-
phine (262 mg, 1 mmol), and tetrabutylammonium bromide
(3.2 g, 10 mmol) were progressively added to a degassed
solution of 3-substituted-3-iodopropenoic acids 1a-f (10 mmol)
in anhydrous DMF (40 mL). The mixture was stirred at room
temperature for 10 min, and allenylstannane (15 mmol) was
then added. The reaction mixture was stirred for 4h after
conversion was complete (checked by TLC), and the reaction
was quenched with aqueous NH4Cl solution. After ether
extraction (3 × 20 mL) and usual treatments, the crude
products were chromatographed on silica gel (hexane/ether )
80/20) to obtain compounds 3a-k.
6-Methyl-2H-pyran-2-one (3a).35 IR (neat) 2960, 2926,
2856, 1732, 1713, 1636, 1559, 1341, 1099; 1H NMR (200 MHz,
CDCl3) δ 2.24 (s, 3H), 5.96 (dd, J ) 6.5 Hz, J ) 0.7 Hz, 1H),
6.1 (dd, J ) 9.4 Hz, J ) 0.7 Hz, 1H), 7.23 (dd, J ) 9.4 Hz, J
) 6.5 Hz, 1H); 13C NMR (50 MHz, CDCl3) δ 20.5, 103.8, 113.5,
144.3, 163.3, 163.5; MS (EI) m/z (%) 110 (M•+, 40), 95 (39), 82
(50), 43 (50), 39 (100). Anal. Calcd for C6H6O2: C, 65.45; H,
5.49. Found: C, 65.40; H, 5.42.
6-Ethyl-4-methoxymethyl-2H-pyran-2-one (3i). IR (neat)
3084, 2995, 2928, 2844, 1738, 1714, 1645, 1568, 1199; 1H NMR
(200 MHz, CDCl3) δ 1.12 (t, J ) 7.5 Hz, 3H), 2.46 (q, J ) 7.5
Hz, 2H), 3.33 (s, 3H), 4.14 (s, 2H), 5.87 (s, 1H), 6.04 (s, 1H);
13C NMR (50 MHz, CDCl3) δ 11.4, 27.3, 59.3, 72.4, 101.1, 108.9,
156.7, 163.5, 167.4; MS (EI) m/z (%) 168 (M•+, 71), 139 (100),
111 (54), 57 (71), 45 (35). Anal. Calcd for C9H12O3: C, 64.27;
H, 7.19. Found: C, 64.20; H, 7.14.
4,6-Dimethyl-2H-pyran-2-one (3b).36 IR (neat) 2959, 2926,
1
1736, 1704, 1651; H NMR (200 MHz, CDCl3) δ 2.14 (s, 3H),
2.24 (s, 3H), 5.87 (s, 1H), 5.97 (s, 1H); 13C NMR (50 MHz,
CDCl3) δ 19.6, 21.2, 106.2, 110.3, 156, 161, 163; MS (EI) m/z
(%) 124 (M•+, 42), 96 (70), 95 (21), 53 (100), 43 (61). Anal. Calcd
for C7H8O2: C, 67.73; H, 6.50. Found: C, 67.68; H, 6.45.
6-Methyl-4-propyl-2H-pyran-2-one (3c). IR (neat) 3071,
2963, 2875, 1770, 1731, 1644, 1562, 1463, 1231; 1H NMR (200
MHz, CDCl3) δ 0.86 (t, J ) 7.3 Hz, 3H), 1.17 (sext, J ) 7.3 Hz,
6-Hexyl-4-methyl-2H-pyran-2-one (3j).21,39 IR (neat) 2958,
1
2930, 2860, 1736, 1647, 1564; H NMR (200 MHz, CDCl3) δ
0.76 (t, J ) 6.3 Hz, 3H), 1.15-1.18 (m, 6H), 1.53 (m, 2H), 2.0
(s, 3H), 2.33 (t, J ) 7.3 Hz, 2H), 5.75 (s, 1H), 5.82 (s, 1H); 13
C
NMR (50 MHz, CDCl3) δ 14.4, 21.8, 22.8, 27.2, 29.0, 31.8, 33.9,
106.1, 110.8, 156.8, 163.8, 165.3; MS (EI) m/z (%) 194 (M•+,
26), 124 (33), 109 (100), 96 (48), 95 (76). Anal. Calcd for
C12H18O2: C, 74.19; H, 9.34. Found: C, 74.13; H, 9.29.
5-Methoxy-4-methoxymehyl-6-methyl-2H-pyran-2-
one (3k). IR (neat) 2994, 2938, 2826, 1738, 1642, 1558, 1230,
(34) (a) Stille, J. K. Angew. Chem., Int. Ed. Engl. 1986, 25, 508. (b)
Stille, J. K.; Groh, B. L. J. Am. Chem. Soc. 1987, 109, 813. (c) Mitchell,
T. N. Synthesis 1992, 803. (d) Farina, V. In Comprehensive Organo-
metallic Chemistry II; Abel, E. W., Stone, F. G., Wilkinson, G., Eds.;
Elsevier: Oxford, 1995; Vol. 12, Chapter 3.4, pp 161-241. (e) Farina,
V.; Roth, G. P. In Advances in Metal-Organic Chemistry; Liebeskind,
L. S., Ed.; JAI Press: New York, 1996; Vol. 5, pp 1-53. (f) Farina, V.;
Krishnamurthy, V.; Scott, W. J. In Org. React.; Paquette, L. A., Ed.;
John Wiley & Sons: New York, 1997; Vol. 50, Chapter 1, pp 1-652.
(g) Farina, V.; Krishnamurthy, V. The Stille Reaction; Wiley: New
York, 1999.
1
1122; H NMR (200 MHz, CDCl3) δ 2.18 (s, 3H), 3.40 (s, 3H),
3.59 (s, 3H), 4.27 (s, 2H), 6.15 (s, 1H); 13C NMR (50 MHz,
CDCl3) δ 15.3, 59.7, 62.5, 68.9, 109.7, 138.5, 154.2, 154.6, 162.4;
MS (EI) m/z (%) 184 (M•+, 23), 169 (22), 141 (22), 43 (100), 39
(14). Anal. Calcd for C9H12O4: C, 58.69; H, 6.57. Found: C,
58.66; H, 6.49.
(35) (a) Kotretsou, S. I.; Georgiadis, M. P. Org. Prep. Proced. Int.
2000, 32, 161. (b) Izumi, T.; Kasahara, A. Bull. Chem. Soc. Jpn. 1975,
48, 1673.
(36) (a) Zhou, M.; Yoshida, Y.; Ishii, S.; Noguchi, H. Synth. Commun.
1999, 29, 2241. (b) Dieter, R. K.; Fishpaugh, J. R. J. Org. Chem. 1988,
53, 2031.
(37) (a) Kalinin, V. N.; Shilova, O. S.; Okladnoi, D. S.; Schmidham-
mer, H. Dokl. Akad. Nauk 1996, 351, 67. (b) Fairlamb, I. J. S.;
Marrison, L. R.; Dickinson, J. M.; Lu, F. J.; Schmidt, J. P. Bioorg. Med.
Chem. 2004, 12, 4285.
(38) Dieter, R. K.; Fishpaugh, J. R. J. Org. Chem. 1987, 52, 923.
(39) Pittet, A. O.; Klaiber, E. M. J. Agric. Food Chem. 1975, 23, 1189.
6674 J. Org. Chem., Vol. 70, No. 17, 2005